Key Details
Price
$2.03Annual EPS
-$0.30Annual ROE
-80.27%Beta
1.21Events Calendar
Next earnings date:
Jan 06, 2025Recent quarterly earnings:
May 13, 2024Recent annual earnings:
Mar 30, 2017Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 10, 2017Analyst ratings
Recent major analysts updates
08 May '15 HC Wainwright & Co.
Buy08 May '15 H.C. Wainwright
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
XTL Biopharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of XTL Biopharmaceuticals?
- What is the ticker symbol for XTL Biopharmaceuticals?
- Does XTL Biopharmaceuticals pay dividends?
- What sector is XTL Biopharmaceuticals in?
- What industry is XTL Biopharmaceuticals in?
- What country is XTL Biopharmaceuticals based in?
- When did XTL Biopharmaceuticals go public?
- Is XTL Biopharmaceuticals in the S&P 500?
- Is XTL Biopharmaceuticals in the NASDAQ 100?
- Is XTL Biopharmaceuticals in the Dow Jones?
- When was XTL Biopharmaceuticals's last earnings report?
- When does XTL Biopharmaceuticals report earnings?
What is the primary business of XTL Biopharmaceuticals?
XTL Biopharmaceuticals (XTLB) is a biotechnology company focused on developing innovative treatments for diseases, particularly in the fields of autoimmune disorders and rare diseases. The company aims to advance its drug candidates through clinical trials to improve patient outcomes and address unmet medical needs.
What is the ticker symbol for XTL Biopharmaceuticals?
The ticker symbol for XTL Biopharmaceuticals is NASDAQ:XTLB
Does XTL Biopharmaceuticals pay dividends?
No, XTL Biopharmaceuticals does not pay dividends
What sector is XTL Biopharmaceuticals in?
XTL Biopharmaceuticals is in the Healthcare sector
What industry is XTL Biopharmaceuticals in?
XTL Biopharmaceuticals is in the Biotechnology industry
What country is XTL Biopharmaceuticals based in?
XTL Biopharmaceuticals is headquartered in Israel
When did XTL Biopharmaceuticals go public?
XTL Biopharmaceuticals's initial public offering (IPO) was on 01 September 2005
Is XTL Biopharmaceuticals in the S&P 500?
No, XTL Biopharmaceuticals is not included in the S&P 500 index
Is XTL Biopharmaceuticals in the NASDAQ 100?
No, XTL Biopharmaceuticals is not included in the NASDAQ 100 index
Is XTL Biopharmaceuticals in the Dow Jones?
No, XTL Biopharmaceuticals is not included in the Dow Jones index
When was XTL Biopharmaceuticals's last earnings report?
XTL Biopharmaceuticals's most recent earnings report was on 13 May 2024
When does XTL Biopharmaceuticals report earnings?
The next expected earnings date for XTL Biopharmaceuticals is 6 January 2025